🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12475+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12475 recruiting trials

NARecruitingNCT06092528

Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency

👨‍⚕️ Betül Yoleri, Pt. MsC, Gazi University📍 1 site📅 Started Nov 2023View details ↗
Phase 1, PHASE2RecruitingNCT06047379

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

👨‍⚕️ Tom Chen, MD, PhD, NeOnc Technologies📍 6 sites📅 Started Nov 2023View details ↗
EARLY_Phase 1RecruitingNCT05343572

Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

👨‍⚕️ Hugh Taylor, MD, Yale University📍 1 site📅 Started Nov 2023View details ↗
RecruitingNCT06145100

Prediction of Portal Hypertension in Patients With CVID (CVID-pHT)

👨‍⚕️ Dominik Bettinger, MD, University Hospital Freiburg📍 1 site📅 Started Nov 2023View details ↗
NARecruitingNCT06113705

Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

👨‍⚕️ Letterio S Politi, MD, Humanitas Research Hospital IRCCS, Rozzano-Milan📍 1 site📅 Started Nov 2023View details ↗
Phase 4RecruitingNCT06040190

Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome

👨‍⚕️ Fernando O Costa, PhD, Federal University of Minas Gerais📍 1 site📅 Started Nov 2023View details ↗
RecruitingNCT06135870

Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)

👨‍⚕️ James Segars, MD, Johns Hopkins University📍 1 site📅 Started Nov 2023View details ↗
RecruitingNCT05855317

Association Between the Level of EV-TF and the Occurence of Pulmonary Embolism in Patients With ARDS

👨‍⚕️ François Cremieux, AP-HM📍 1 site📅 Started Oct 2023View details ↗
RecruitingNCT06991881

Eosinophilic Esophagitis: Towards Improved Management

👨‍⚕️ Ketil Størdal, PhD, University of Oslo📍 2 sites📅 Started Oct 2023View details ↗
Phase 1, PHASE2RecruitingNCT05906953

Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR)

👨‍⚕️ Study Director, HuidaGene Therapeutics Co., Ltd.📍 3 sites📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT06081959

Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer

🏥 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.📍 1 site📅 Started Oct 2023View details ↗
Phase 1RecruitingNCT05995041

Universal CAR-T Cells Targeting AML

🏥 Shenzhen Geno-Immune Medical Institute📍 1 site📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT06004336

A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)

👨‍⚕️ Chad Tang, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Oct 2023View details ↗
Phase 1RecruitingNCT05995028

Universal 4SCAR7U Targeting CD7-positive Malignancies

🏥 Shenzhen Geno-Immune Medical Institute📍 1 site📅 Started Oct 2023View details ↗
RecruitingNCT05935007

Aveir DR Real-World Evidence Post-Approval Study

👨‍⚕️ Nicole Harbert, Abbott📍 1 site📅 Started Oct 2023View details ↗
NARecruitingNCT06017895

Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma

👨‍⚕️ Jian Guan, MD, Nanfang Hospital, Southern Medical University📍 1 site📅 Started Oct 2023View details ↗
RecruitingNCT05932602

AVEIR DR Coverage With Evidence Development (CED) Study

👨‍⚕️ Nicole Harbert, Abbott📍 1 site📅 Started Oct 2023View details ↗
Phase 2RecruitingNCT05852717

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

👨‍⚕️ Dipenkumar Modi, MD, Wayne State University📍 4 sites📅 Started Oct 2023View details ↗
NARecruitingNCT05793151

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

👨‍⚕️ Evan M Graboyes, MD, MPH, Medical University of South Carolina📍 4 sites📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT05943535

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

🏥 United Therapeutics📍 150 sites📅 Started Oct 2023View details ↗
← PreviousPage 365 of 624Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →